Loading clinical trials...

COMPLETEDPhase 1NCT03611569

Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease

The purpose of this study is to investigate the safety of a single dose of Lu AF82422, how well it is tolerated, how the drug effects the body and what the body does to the drug in healthy non-Japanes...

Lead sponsor: H. Lundbeck A/S•4 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Cytapheresis of Volunteer Donors

NCT00104325 · Healthy Volunteers

RECRUITINGPhase 1

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

NCT07470866 · Healthy

RECRUITINGPhase 1

A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

NCT06637865 · Healthy

RECRUITINGPhase 1

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

NCT07388667 · Healthy

RECRUITING

Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD

NCT07187843 · Parkinson Disease, Parkinsonian Disorders, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 12, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment74

Start dateJul 2018

Last updatedOct 12, 2021

Condition

Healthy Parkinson Disease

Locations shown

California Clinical Trials Medical Group (CCTMG)

Glendale, California

Reserach Center of America

Hollywood, Florida

PPD

Orlando, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 12, 2021Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Cytapheresis of Volunteer Donors

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PD

Trial snapshot

Condition

Locations shown

For caregivers